waper
Start free

Health research digest

Important medical research findings, drug and therapy progress, and regulatory approvals.

  • Official
  • 1 follower
Sign up to followCustomize it

You're reading the brief from Sun, Oct 11.Back to the latest brief

Sun, Oct 11

5 items
0 of 5 read

A modeling study suggests that better blood-pressure control could prevent over half a million cardiovascular deaths a year across 20 countries, while a year-long trial finds that changing how you walk can ease knee arthritis pain.

Research

Blood pressure control could avert 518,000 CVD deaths yearly

Preliminary research presented at the American Heart Association's Hypertension Scientific Sessions 2026 estimates that effective high blood pressure management could prevent more than 518,000 cardiovascular deaths annually across 20 countries.

Why it mattersScaling up existing hypertension treatment could yield large population-level mortality gains without new drugs.

Research

Gait change cuts knee arthritis pain in year-long trial

In a year-long clinical trial, adjusting the angle of the foot while walking reduced osteoarthritis pain by an amount comparable to medication, and MRI scans showed slower joint damage in those who adopted the change.

Why it mattersA drug-free, surgery-free intervention could offer a low-cost option for a common and disabling condition.

Research

Mouse study finds previously unknown eye drainage pathway

Scientists discovered a hidden cleanup system at the back of the eye that drains fluid and waste through a previously unknown pathway, demonstrated in mice.

Why it mattersIf confirmed in humans, the pathway could open new treatments for glaucoma and macular degeneration.

Research

Polyethylene microplastics linked to fatty liver disease

Texas A&M researchers found that polyethylene microplastics can contribute to fatty liver disease, with potentially worse effects when combined with an unhealthy diet.

Why it mattersA ubiquitous plastic previously considered relatively harmless may be an underrecognized liver risk.

Research

Aspirin rarely used for colorectal cancer prevention

Although the CAPP2 study showed that 600 mg of acetylsalicylic acid daily significantly reduced long-term colorectal cancer risk in people with Lynch syndrome, a recent publication indicates the drug is rarely used for prevention in this high-risk group.

Why it mattersA proven preventive option in a high-risk population appears to be underused in practice.

Ask this brief

Sign in to ask questions about this brief.

Recent briefs

  1. Mon, Oct 124 itemsToday's digest covers reassuring safety data on first-trimester benzodiazepine use, a large U.S. study linking radon exposure to brain cancer risk, and a possible shared driver of liver and pancreas dysfunction in type 2 diabetes.
  2. Sun, Oct 115 itemsA modeling study suggests that better blood-pressure control could prevent over half a million cardiovascular deaths a year across 20 countries, while a year-long trial finds that changing how you walk can ease knee arthritis pain.
  3. Sat, Oct 106 itemsA short immunotherapy course before surgery kept stage 2-3 bowel cancer from returning in a small trial, while Florida's dengue outbreak grew into the largest in any U.S. state in decades.
  4. Fri, Oct 95 itemsThis week's digest is led by a Phase 3 failure for Argenx's Vyvgart in Sjögren's disease and an FDA safety signal after four deaths in a schizophrenia drug trial. Other notable items include a major review favoring nicotine e-cigarettes for quitting, preclinical progress on osteoarthritis and lymphoma, and an FDA request for input on ibogaine trials.

Who and what it tracks

  • FDAOrganization2
  • WHOOrganization2